Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Comparison Results
Name | Price | Price Change | Volume | Market Cap | Analyst Price Target | Analyst Consensus | Smart Score | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|
 AstraZeneca | 12028.00p | 92p (0.76%) | 136.97K | £187.68B | xxxxxxxxxxxxx | 11 Buy 4 Hold 1 Sell Moderate Buy | |||
 GlaxoSmithKline | 1507.75p | 3.5p (0.23%) | 887.38K | £61.60B | xxxxxxxxxxxxx | 7 Buy 5 Hold 2 Sell Moderate Buy | |||
 Hikma Pharmaceuticals | 1816.00p | 18p (0.98%) | 13.34K | £4.06B | xxxxxxxxxxxxx | 2 Buy 4 Hold 0 Sell Moderate Buy | |||
 HUTCHMED (China) Limited | 266.00p | 8p (2.92%) | 13.02K | £2.38B | xxxxxxxxxxxxx | 1 Buy 0 Hold 0 Sell Moderate Buy | |||
 | ― | ― | ― | ― | xxxxxxxxxxxxx | ― |
Performance Comparison
GB:AZN
AstraZeneca
12,106.00
2,002.78
19.82%
GB:GSK
GlaxoSmithKline
1,510.50
224.01
17.41%
GB:HIK
Hikma Pharmaceuticals
1,831.00
30.94
1.72%
GB:HCM
HUTCHMED (China) Limited
266.00
72.40
37.40%
GB:DPH
―
3,866.00
186.00
5.05%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Pharma & Biotech Stocks Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Apr 25, 2024
Mar 01, 2024
215
GlaxoSmithKline
May 01, 2024
Mar 01, 2024
38.8
Hikma Pharmaceuticals
Feb 22, 2024
Dec 01, 2023
127.9
HUTCHMED (China) Limited
Feb 28, 2024
Dec 01, 2023
1.906
―
―
―
―
Pharma & Biotech Stocks - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 12,028.00p, and its average 12-month price target is 13,197.25p.
GlaxoSmithKline's stock price is currently 1,507.75p, and its average 12-month price target is 1,873.50p.
Hikma Pharmaceuticals's stock price is currently 1,816.00p, and its average 12-month price target is 2,270.83p.
HUTCHMED (China) Limited's stock price is currently 266.00p, and its average 12-month price target is 358.19p.
's stock price is currently N/A, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline does not currently pay dividends.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) Limited does not currently pay dividends.
does not currently pay dividends.
Popular Stocks Comparisons
Latest News
Pharma & Biotech Stock Events
Stock | Type | Date |
|---|---|---|
AstraZeneca | Earnings Release | Jul 25, 2024 |
GlaxoSmithKline | Earnings Release | Jul 31, 2024 |
HUTCHMED (China) Limited | Earnings Release | Jul 31, 2024 |
Hikma Pharmaceuticals | Earnings Release | Aug 08, 2024 |
Dechra Pharmaceuticals | Earnings Release | Sep 02, 2024 |